A novel intronic variant in PIGB in Acrofrontofacionasal dysostosis type 1 patients expands the spectrum of phenotypes associated with GPI biosynthesis defects.

Acrofrontofacionasal dysostosis type 1 Dysmorphisms Glycosylphosphatidylinositol anchor synthesis Neurodevelopmental delay PIGB

Journal

Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048

Informations de publication

Date de publication:
12 2021
Historique:
received: 07 06 2021
revised: 09 08 2021
accepted: 10 08 2021
pubmed: 18 8 2021
medline: 26 10 2021
entrez: 17 8 2021
Statut: ppublish

Résumé

Acrofrontofacionasal dysostosis type 1 (AFFND1) is an extremely rare disorder characterized by several dysmorphic features, skeletal abnormalities and intellectual disability, and described only in seven patients in the literature. A biallelic variant in the Neuroblastoma Amplified Sequence (NBAS) gene was recently identified in two Indian patients with AFFND1. Here we report genetic investigation of AFFND1 in the originally described Brazilian families and the identification of an extremely rare, recessively-inherited, intronic variant in the Phosphatidylinositol Glycan class B (PIGB) gene NC_000015.10 (NM_004855.4): c.795-19T > G) in the affected individuals. The PIGB gene encodes an enzyme involved in the biosynthesis of the glycosylphosphatidylinositol (GPI) anchor, which is required for the post-translational modification of a large variety of proteins, enabling their correct cellular localization and function. Recessive variants in PIGB have previously been reported in individuals with a neurodevelopmental syndrome having partial overlap with AFFND1. In vitro assays demonstrated that the intronic variant leads to exon skipping, suggesting the Brazilian AFFND1 patients may be null for PIGB, in agreement with their severe clinical phenotype. These data increase the number of pathogenic variants in the PIGB gene, place AFFND1 among GPI deficiencies and extend the spectrum of phenotypes associated with GPI biosynthesis defects.

Identifiants

pubmed: 34400385
pii: S8756-3282(21)00318-5
doi: 10.1016/j.bone.2021.116152
pii:
doi:

Substances chimiques

Glycosylphosphatidylinositols 0
Mannosyltransferases EC 2.4.1.-
PIGB protein, human EC 2.4.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

116152

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Eleonora Palagano (E)

CNR-IRGB, Milan Unit, Milan, Italy; IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.

Christopher T Gordon (CT)

INSERM UMR1163, Institut Imagine, Université de Paris, Paris, France.

Paolo Uva (P)

IRCCS G. Gaslini, Genoa, Italy; Italian Institute of Technology, Genoa, Italy.

Dario Strina (D)

CNR-IRGB, Milan Unit, Milan, Italy; IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.

Clémantine Dimartino (C)

INSERM UMR1163, Institut Imagine, Université de Paris, Paris, France.

Anna Villa (A)

CNR-IRGB, Milan Unit, Milan, Italy; San Raffaele Telethon Institute for Gene Therapy SR-Tiget, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Jeanne Amiel (J)

INSERM UMR1163, Institut Imagine, Université de Paris, Paris, France; Service de Génétique, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.

Maria L Guion-Almeida (ML)

Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies (HRCA), University of São Paulo, Bauru, Brazil.

Siulan Vendramini-Pittoli (S)

Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies (HRCA), University of São Paulo, Bauru, Brazil.

Nancy M Kokitsu-Nakata (NM)

Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies (HRCA), University of São Paulo, Bauru, Brazil.

Roseli M Zechi-Ceide (RM)

Department of Clinical Genetics, Hospital for Rehabilitation of Craniofacial Anomalies (HRCA), University of São Paulo, Bauru, Brazil.

Cristina Sobacchi (C)

CNR-IRGB, Milan Unit, Milan, Italy; IRCCS Humanitas Research Hospital, Rozzano (MI), Italy. Electronic address: cristina.sobacchi@humanitasresearch.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH